Description
Lusutrombopag
Each film-coated tablet contains: Lusutrombopag … 3mg.
INDICATIONS
LuciLusu is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
DOSAGE AND USE
Begin LuciLusu dosing 8-14 days prior to a scheduled procedure. Patients should undergo their procedure 2-8 days after the last dose. Recommended Dosage: 3 mg orally once daily with or without food for 7 days.
STORAGE
In a dry place and store at 20℃ to 25℃.
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNINGS
Keep medicine out of reach of Children. Do not administer LuciLusu during Pregnancy and Lactation.
Reviews
There are no reviews yet.